
Supira Medical nets $120m to advance ventricular support device
US-based Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the percutaneous ventricular assist device (pVAD) market. A portfolio company of the Shifamed medical technology innovation hub …